Description

4-[(5Z)-5-({3-[4-(Butylsulfanyl)Phenyl]-1-Phenyl-1H-Pyrazol-4-Yl}Methylidene)-4-Oxo-2-Thioxo-1,3-Thiazolidin-3-Yl]Butanoic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting specific enzymatic pathways. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and development programs. The product is supplied with full analytical documentation to ensure batch-to-batch consistency and support regulatory filings.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel therapeutic agents, particularly in oncology and anti-inflammatory research.
• Drug Discovery & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Biochemical Research: Employed as a reference standard or probe molecule in enzymatic and receptor-binding assays.
• Advanced Material Synthesis: Potential use in creating specialized organic compounds for material science applications.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.

Basic Information

Product Name	4-[(5Z)-5-({3-[4-(Butylsulfanyl)Phenyl]-1-Phenyl-1H-Pyrazol-4-Yl}Methylidene)-4-Oxo-2-Thioxo-1,3-Thiazolidin-3-Yl]Butanoic Acid
CAS No.	1009433-98-0
Molecular Formula	C27H25N3O3S3
Molecular Weight	535.70 g/mol
Synonyms	4-[(5Z)-5-({3-[4-(Butylthio)Phenyl]-1-Phenyl-1H-Pyrazol-4-Yl}Methylene)-4-Oxo-2-Thioxo-1,3-Thiazolidin-3-Yl]Butanoic Acid; 4-[(5Z)-5-[[3-[4-(Butylsulfanyl)phenyl]-1-phenyl-1H-pyrazol-4-yl]methylene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid; Butanoic acid, 4-[(5Z)-5-[[3-[4-(butylthio)phenyl]-1-phenyl-1H-pyrazol-4-yl]methylene]-4-oxo-2-thioxo-3-thiazolidinyl]-; 1009433-98-0; 4-{[(5Z)-5-({3-[4-(Butylsulfanyl)phenyl]-1-phenyl-1H-pyrazol-4-yl}methylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]}butanoic acid
EINECS	Contact for details

Quality Control

Every batch of 4-[(5Z)-5-({3-[4-(Butylsulfanyl)Phenyl]-1-Phenyl-1H-Pyrazol-4-Yl}Methylidene)-4-Oxo-2-Thioxo-1,3-Thiazolidin-3-Yl]Butanoic Acid is manufactured under strict quality management systems and undergoes comprehensive analytical testing. Our products are characterized using advanced techniques including HPLC, NMR, and MS to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting all critical quality attributes to support your research and development needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. For long-term storage, consider storing under an inert atmosphere to ensure maximum stability.

Specification

Item	Specification
Appearance	Yellow to brown powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.